Evotec SE (EVO) Accounts Payables (2020 - 2026)
Evotec SE's (EVO) quarterly Accounts Payables came in at $64273.9 in Q1 2026, little changed year-on-year from $64479.5 in Q1 2025, and down 14.74% quarter-over-quarter from $75387.0 in Q4 2025.
Evotec SE (EVO) Accounts Payables (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Accounts Payables across 7 years of filings, most recently posting $64273.9 for Q1 2026.
- Accounts Payables for Q1 2026 came in at $64273.9, changed 0.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $64273.9 (changed 0.32% YoY), and the FY2025 annual result was $75387.0, down 99.92% from the prior year.
- Accounts Payables came in at $64273.9 for Q1 2026 at Evotec SE, down from $75387.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $144.5 million in Q4 2023 to a low of -$86317.4 in Q2 2022.
- The 5-year median for Accounts Payables is $76073.0 (2024), against an average of $28.0 million.
- Across the five-year window, Accounts Payables surged 45.62% in 2023 and plunged 99.92% in 2025, its largest moves.
- Evotec SE's Accounts Payables stood at $99.2 million in 2022, then soared by 45.62% to $144.5 million in 2023, then plunged by 36.56% to $91.7 million in 2024, then slumped by 99.92% to $75387.0 in 2025, then dropped by 14.74% to $64273.9 in 2026.
- The last three Accounts Payables figures came in at $64273.9 (Q1 2026), $75387.0 (Q4 2025), and $57850.7 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 45.88 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 306.87 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 64,273.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,273.94 |
| Dec 31, 2025 | 75,386.95 |
| Sep 30, 2025 | 57,850.69 |
| Jun 30, 2025 | 65,635.55 |
| Mar 31, 2025 | 64,479.46 |
| Dec 31, 2024 | 91.68 Mn |
| Sep 30, 2024 | 76,758.95 |
| Dec 31, 2023 | 144.52 Mn |
| Dec 31, 2022 | 99.25 Mn |
| Sep 30, 2022 | 84,659.75 |
| Jun 30, 2022 | -86,317.42 |
| Mar 31, 2022 | 83,882.40 |
| Dec 31, 2021 | 83.05 Mn |
| Sep 30, 2021 | 66,889.18 |
| Dec 31, 2020 | 50.73 Mn |